# A Phase II Study of TollB-001 Tablets in Systemic Sclerosis

> clinical trial · VERIFIED · 2026-08-04

Status: NOT_YET_RECRUITING · Sponsor: Toll Biotech Co. Ltd. (Beijing) · Condition: Systemic Sclerosis (SSc)

- Company: Toll Biotech Co. Ltd. (Beijing)
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07745725

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.